A systematic review and meta-analysis finds that GLP-1-based treatments drive clinically meaningful weight loss mainly through fat reduction, but experts warn that preserving muscle remains essential for long-term metabolic health
ManellHStaafJManukyanLKristinssonHCenJStenlidRet al
Adv Drug Delivery Rev 42:225238 Lewis AL, Mcentee N, Holland J, Patel A (2022) Development and approval of rybelsus (oral semaglutide): ushering in a new era in peptide delivery
Food and Drug Administration approving their use for chronic weight management and celebrity endorsements
Lipotropic injections support energy and metabolism alongside a weight-loss program, whether that is our Weight Loss Program, Thinnr, or the Phentermine Program
Similar findings were reported in the Sri Lankan population [24, 41]